Studies[31–33] show that oXiris can improve the hemodynamic status of patients with sepsis by removing inflammatory mediators, such as tumor necrosis factor-α, IL-6, IL-8, and interferon-γ, ultimately improving patient outcomes. This evidence concerns the gene IL6 and Sepsis.